angelica
keiskei
miq
koidz
umbellifera
tradit
use
treat
dysuria
dyschezia
dysgalactia
well
restor
vital
recent
aerial
part
keiskei
consum
health
food
variou
flavonoid
coumarin
phenol
acetylen
sesquiterpen
diterpen
triterpen
identifi
constitu
keiskei
crude
extract
pure
constitu
proven
inhibit
tumor
growth
amelior
inflamm
obes
diabet
hypertens
ulcer
extract
also
show
antithrombot
antioxid
antihyperlipidem
antivir
antibacteri
activ
valuabl
herb
need
studi
develop
treat
human
diseas
also
improv
human
health
current
keiskei
commerci
health
food
addit
health
drink
articl
present
comprehens
review
keiskei
potenti
place
improv
human
health
angelica
keiskei
miq
koidz
hardi
perenni
belong
famili
umbellifera
keiskei
tradit
use
diuret
mild
cathart
tonic
galactagogu
kimura
baba
herb
call
myeongil
yeob
korea
ashitaba
japan
liter
mean
tomorrow
leaf
baba
et
al
anoth
common
name
keiskei
shinsun
cho
mean
preciou
herb
use
god
keiskei
mainli
distribut
asian
countri
includ
korea
japan
park
aerial
part
mainli
use
sourc
green
veget
juic
daili
health
food
young
leav
aerial
part
use
parboil
deepfri
imai
imai
aerial
part
also
use
tea
flour
wine
cosmet
bao
su
ku
et
al
liu
et
al
review
paper
summar
botan
characterist
phytochem
research
well
biolog
studi
extract
pure
constitu
keiskei
extract
report
antiinflammatori
antiobes
antioxid
anticoagul
antitumor
antimutagen
antidiabet
antibacteri
hepatoprotect
activ
biolog
activ
pure
compound
also
separ
summar
review
angelica
keiskei
glossi
leav
flower
summer
fall
leav
harvest
spring
fall
lose
gloss
yellow
exud
squeez
stem
leav
harvest
imai
imai
yellow
color
make
easi
distinguish
keiskei
japonica
exud
show
nearli
white
color
characterist
botan
featur
keiskei
describ
flora
japan
rhizom
thick
short
elong
root
stem
stout
branch
cm
long
glabrou
leav
radic
lower
caulin
usual
evergreen
obtus
deltoid
outlin
cm
long
glabrou
leaflet
rather
thick
usual
deepli
cleft
part
segment
usual
ovat
cm
long
cm
wide
acut
tooth
impress
veinlet
upper
side
sheath
upper
part
ellipt
inflat
infloresc
umbel
rather
numer
peduncl
upper
part
inner
side
ray
pedicel
puberul
ray
pedicel
bracteol
involucel
sever
linear
slightli
broaden
base
caudat
elong
slightli
longer
shorter
pedicel
style
short
long
stylopodium
fruit
oblong
glabrou
mm
long
flat
dorsal
rib
short
rather
thick
later
rib
wing
vitta
interv
commissur
oi
et
al
previou
phytochem
investig
keiskei
led
identif
compound
includ
variou
type
flavonoid
coumarin
phenol
acetylen
sesquiterpen
diterpen
triterpen
structur
report
constitu
list
tabl
shown
fig
recent
studi
aerial
part
keiskei
eight
constitu
chalcon
chalcon
chalcon
methoxychalcon
methoxychalcon
methoxychalcon
methyl
chalcon
hydroxyangelichalcon
isol
report
new
compound
ethyl
acet
extract
along
eight
known
compound
xanthoangelol
xanthoangelol
f
xanthoangelol
g
xanthoangelol
xanthoangelol
e
xanthoangelol
h
chalcon
artocarmitin
ci
r
methylkhellacton
tran
methylkhellacton
z
pcoumaryl
alcohol
kil
et
al
kil
et
al
particular
xanthoangelol
isol
bulk
g
g
support
two
chalcon
predomin
constitu
herb
part
research
aerial
part
keiskei
effect
method
develop
prepar
two
chalcon
crude
extract
use
highspe
countercurr
chromatographi
twophas
solvent
system
nhexaneethyl
acetatemethanolwat
revolut
rate
rpm
flow
rate
ml
min
kil
et
al
nhexan
fraction
ethanol
extract
aerial
part
keiskei
show
inhibitori
effect
product
lipopolysaccharid
lp
induc
nitric
oxid
prostaglandin
e
pge
downregul
induc
synthas
ino
protein
mrna
lee
et
al
ethyl
acet
fraction
also
inhibit
product
lpsactiv
raw
cell
chang
et
al
studi
mice
ethyl
acet
extract
report
prevent
highfat
diet
induc
adipos
modul
lipid
metabol
increas
phosphoryl
adenosin
monophosphateactiv
protein
kinas
ampk
adipos
tissu
liver
patent
file
antiobes
activ
ethanol
extract
aerial
part
keiskei
mice
lee
et
al
dietari
keiskei
ethyl
acet
extract
yellow
exud
produc
elev
serum
highdens
lipoprotein
hdl
level
contain
apolipoprotein
apo
reduct
liver
triglycerid
tg
level
decreas
mrna
express
hepat
acylcoenzym
coa
synthetas
strokepron
spontan
hypertens
rat
shrsp
ogawa
et
al
ethyl
acet
fraction
methanol
extract
show
inhibitori
effect
coa
hmgcoa
reductas
crucial
rate
limit
enzym
biosynthesi
cholesterol
park
et
al
impact
keiskei
examin
rat
fed
high
fat
diet
shown
liver
weight
decreas
gene
express
antioxid
enzym
catalas
glutathionesreductas
liver
increas
kim
et
al
addit
treatment
ethanol
extract
reduc
increas
level
serum
insulin
triglycerid
rat
drink
fructos
ethanol
extract
enhanc
express
gene
relat
fatti
acid
boxid
hdl
product
acylcoa
oxidas
mediumchain
acylcoa
dehydrogenas
mcad
atpbind
membran
cassett
transport
gene
fructos
fed
rat
ohnogi
et
al
alcohol
extract
keiskei
evalu
scaveng
capabl
superoxid
anion
dpph
free
radic
result
decreas
free
radic
format
scaveng
effect
leav
extract
greater
stem
extract
qin
et
al
guo
et
al
exud
keiskei
result
anticoagul
inhibit
elev
plasma
plasminogen
activ
inhibitor
inflammatori
condit
induc
lp
ohkura
et
al
methanol
extract
root
show
antiplatelet
activ
evalu
wash
rabbit
platelet
model
system
son
et
al
cancer
cell
line
studi
increas
express
level
proapoptot
gene
apoptot
induc
gene
b
cell
lymphoma
decreas
express
level
apoptot
suppressor
gene
associ
x
bax
present
mechan
action
anticanc
effect
keiskei
jeong
kang
methanol
extract
show
antimutagen
activ
aflatoxin
nmethyln
nitronnitrosoguanidin
kozawa
et
al
rt
antiulc
activ
gastric
h
k
atpas
murakami
et
al
rt
antibacteri
activ
gramposit
bacteria
inamori
et
al
syn
ap
antioxid
activ
dpph
radic
scaveng
kim
et
al
hyperosid
first
isol
part
park
et
al
ap
anticholesterogen
activ
hmgcoa
reductas
park
et
al
ap
antimutagen
activ
park
et
al
ap
antioxid
activ
dpph
radic
scaveng
kim
et
al
quercitrin
rt
ngf
product
enhanc
effect
mous
fibroblast
detail
patent
ohnogi
et
al
psoralen
angelicin
rt
first
isol
part
hata
kozawa
columbianadin
nucleosid
salmonella
assay
system
park
et
al
ethanol
extract
exhibit
insulinlik
activ
pathway
independ
peroxisom
proliferatoractiv
receptorc
pparc
activ
longterm
ingest
powder
keiskei
improv
blood
glucos
control
moder
safe
reduc
blood
glucos
patent
file
benefici
effect
keiskei
diabet
lee
et
al
exud
keiskei
show
antibacteri
activ
helicobact
pylori
suggest
keiskei
prevent
agent
gastriti
fukuo
et
al
patent
exud
file
control
mouth
odor
antibacteri
activ
fusobacterium
nucleatum
saeki
et
al
clinic
trial
habitu
alcohol
drinker
abnorm
liver
function
test
also
show
intak
extract
significantli
reduc
cglutamyl
transferas
ggt
level
noh
et
al
patent
file
benefici
activ
ethanol
extract
root
improv
liver
function
reliev
fatigu
kim
et
al
addit
activ
ethanol
extract
also
show
antihypertens
activ
inhibit
angiotensin
enzym
ace
spontan
hypertens
rat
similar
nicotianamin
shimizu
et
al
green
juic
keiskei
proven
protect
lymphocyt
dna
damag
smoker
report
potenti
reduc
risk
lung
cancer
clinic
trial
kang
et
al
anoth
clinic
studi
consum
drink
powder
leav
three
time
day
week
allevi
mild
constip
improv
defec
kusaba
et
al
deficit
learn
memori
caus
alzheim
diseas
age
may
allevi
keiskei
sinc
shown
plant
capabl
restor
scopolaminereduc
phosphoryl
cyclic
adenosin
monophosph
camp
respons
elementbind
protein
creb
express
brainderiv
neurotroph
factor
bdnf
mous
hippocampu
oh
et
al
topic
use
extract
shown
whiten
skin
tyrosinas
inhibitori
effect
higa
lee
et
al
promot
hair
growth
sakaguchi
et
al
patent
applic
isol
keiskei
show
divers
biolog
activ
especi
two
major
chalcon
xanthoangelol
extens
park
et
al
saccharid
sucros
ap
first
isol
part
park
et
al
ap
antimutagen
activ
park
et
al
acid
angel
acid
rt
first
isol
part
hata
kozawa
behen
acid
rt
first
isol
part
hata
kozawa
other
protect
effect
damag
cell
hspinduc
agent
may
act
prospect
agent
protect
normal
cell
chemotherapi
induc
advers
effect
chalcon
lm
increas
express
protein
h
treatment
mrna
level
h
lower
cytotox
celastrol
posit
control
kil
et
al
xanthoangelol
inhibit
h
k
atpas
gastric
microsom
vesicl
prepar
pig
fundic
mucosa
addit
downregul
k
stimul
pnitrophenyl
phosphatas
xanthoangelol
reduc
format
stressinduc
gastric
lesion
well
acid
secret
rat
murakami
et
al
xanthoangelol
e
also
found
antiulc
activ
patent
murakami
et
al
murakami
et
al
xanthoangelol
show
antibacteri
activ
gramposit
bacteria
bacillu
subtili
b
subtili
b
cereu
staphylococcu
aureu
aureu
aureu
micrococcu
luteu
gramneg
bacteria
although
antibacteri
activ
lower
gentamicin
aforement
bacteria
antibacteri
activ
xanthoangelol
luteu
strong
gentamicin
mic
lgml
inamori
et
al
mechan
antibacteri
activ
aureu
elucid
util
chemic
cleavabl
linker
due
heat
sensit
report
isol
inhibit
amino
acyl
trna
catalyz
aureu
seryltrna
synthetas
essenti
enzymat
pathway
bacteri
viabil
battenberg
et
al
two
chalcon
exhibit
antibacteri
activ
plantpathogen
bacteria
agrobacteriu
tumefacien
pseudomona
syringa
pv
phaseolicola
p
syringa
pv
tabaci
p
stutzeri
inamori
et
al
sugamoto
et
al
bioactiv
compound
antitumorpromot
antitumoriniti
antimutagen
activ
may
consid
chemoprevent
therapeut
agent
two
angular
furanocoumarin
r
hydroxycolumbianadin
archangelicin
three
chalcon
xanthoangelol
ashitabachalcon
inhibit
tpa
stimul
piincorpor
phospholipid
cultur
cell
xanthoangelol
show
antitumorpromot
activ
mous
skin
carcinogenesi
induc
anthracen
dmba
plu
tpa
via
modul
ca
calmodulin
system
okuyama
et
al
isobavachalcon
exhibit
inhibitori
effect
skin
tumor
promot
vivo
twostag
mous
skin
carcinogenesi
test
akihisa
et
al
inhibitori
effect
induct
epsteinbarr
viru
earli
antigen
ebvea
tpa
raji
cell
found
xanthoangelol
xanthoangelol
f
isobavachalcon
xanthoangelol
h
xanthoangelol
xanthoangelol
j
munduleaflavanon
munduleaflavanon
b
isobavachin
prostratol
f
ogeranylnaringenin
osthenol
r
hydroxycolumbianidin
senecioyl
khellacton
r
angeloyl
khellacton
miswritten
isolaserapitin
articl
senecioyl
khellacton
isolemanidin
miswritten
laserapitin
articl
pteryxin
akihisa
et
al
akihisa
et
al
xanthoangelol
f
isobavachalcon
xanthoangelol
xanthoangelol
j
munduleaflavanon
b
sophoraflavanon
osthenol
selinidin
khellacton
r
angeloyl
khellacton
miswritten
isolaserapitin
articl
khellacton
isolemanidin
miswritten
laserapitin
articl
pteryxin
inhibit
activ
e
e
hydroxyimino
donor
akihisa
et
al
akihisa
et
al
cynarosid
hyperosid
sucros
show
antimutagen
activ
aflatoxin
park
et
al
previou
studi
xanthoangelol
identifi
activ
compound
inhibit
tumor
growth
lewi
lung
carcinoma
llc
bear
mice
prolong
surviv
time
suppress
metastasi
lung
surgic
remov
primari
tumor
activ
ethyl
acet
fraction
ethanol
extract
kimura
baba
kimura
et
al
antitumor
activ
xanthoangelol
might
deriv
inhibitori
effect
dna
synthesi
llc
cell
tumorinduc
neovascular
reduc
format
capillarylik
tube
vascular
endotheli
cell
adhes
vascular
endotheli
growth
factor
vegf
human
umbil
vein
endotheli
cell
huvec
kimura
baba
also
inhibit
dna
synthesi
llc
cell
format
capillarylik
tube
reduc
adhes
vascular
endotheli
growth
factor
vegf
huvec
instead
suppress
reduct
lymphocyt
natur
killer
nk
cell
spleen
tumorremov
mice
kimura
et
al
xanthoangelol
induc
apoptot
cell
death
activ
neuroblastoma
leukemia
jurkat
cell
mechan
independ
signal
transduct
tabata
et
al
ongo
studi
reveal
detail
mechan
action
xanthoangelol
induc
apoptosi
trigger
oxid
stress
gener
reactiv
oxygen
speci
downregul
antioxid
protein
cell
motani
et
al
xanthoangelol
show
cytotox
effect
sever
neuroblastoma
cell
line
includ
drugresist
cell
well
drugsensit
sknsh
cell
nishimura
et
al
motani
et
al
xanthoangelol
f
isobavachalcon
xanthoangelol
h
xanthoangelol
cytotox
cell
isobavachalcon
found
induc
apoptot
cell
death
neuroblastoma
cell
via
mitochondri
pathway
includ
reduct
induct
bax
level
cytotox
normal
cell
nishimura
et
al
xanthoangelol
inhibit
growth
human
stomach
cancer
kato
iii
cell
induct
apoptosi
fragment
dna
takaoka
et
al
exhibit
cytotox
activ
human
leukemia
melanoma
lung
cancer
stomach
cancer
cell
cytotox
cell
caus
induct
apoptosi
inhibit
dna
topoisomeras
reduc
akihisa
et
al
genet
diabet
kka
mous
model
xanthoangelol
show
insulinlik
activ
enhanc
glucos
uptak
induc
preadipocyt
differenti
adipocyt
without
activ
pparc
also
prevent
progress
diabet
mice
basi
prevent
effect
clinic
trial
perform
keiskei
powder
contain
result
reduct
blood
glucos
improv
blood
glucos
control
increas
adiponectin
subject
borderlin
mild
hyperglycemia
week
consumpt
keiskei
xanthoangelol
isobavachalcon
munduleaflavanon
demethylsuberosin
senecioyl
khellacton
falcarindiol
z
acet
appear
inhibit
aglucosidas
involv
glucos
metabol
luo
et
al
xanthoangelol
stimul
skelet
muscleassoci
glucos
uptak
induc
glucos
transport
transloc
result
normal
blood
glucos
level
kawabata
et
al
recent
protein
tyrosin
phosphatas
suggest
therapeut
target
treatment
type
diabet
base
downregul
effect
insulin
signal
li
et
al
evalu
isol
stem
keiskei
inhibitori
effect
use
oleanol
acid
posit
control
xanthoangelol
xanthoangelol
f
xanthoangelol
xanthoangelol
e
xanthoangelol
k
xanthoangelol
bergapten
miswritten
methoxsalen
articl
show
strong
inhibitori
effect
ic
lgml
togeth
moder
activ
four
compound
selinidin
khellacton
falcarindiol
lgml
weakli
activ
one
cynarosid
ic
lg
ml
furthermor
kinet
studi
xanthoangelol
ic
valu
lgml
exhibit
typic
characterist
competit
inhibitor
molecular
dock
simul
suggest
ring
b
chalcon
skeleton
may
anchor
pocket
li
et
al
onogi
et
al
file
patent
applic
present
angelichalcon
nerv
cell
protect
effect
onogi
et
al
addit
coumarin
report
enhanc
effect
nerv
growth
factor
ngf
product
mous
fibroblast
lm
cell
patent
ohnogi
et
al
show
hypolipidem
activ
administr
intraperiton
inject
rat
park
et
al
cynarosid
hyperosid
exhibit
anticholesterogen
activ
inhibit
hmgcoa
reductas
park
et
al
shrsp
fed
diet
contain
week
serum
lowdens
lipoprotein
vldl
hepat
triglycerid
tg
level
significantli
reduc
without
effect
serum
hdl
level
consid
microsom
tg
transferprotein
may
respons
decreas
serum
vldl
level
differenti
factor
fatti
acid
synthas
may
induc
decreas
hepat
tg
content
ogawa
et
al
case
isolemanidin
miswritten
laserapitin
articl
serum
hdl
level
especi
apoehdl
increas
hepat
tg
content
decreas
might
relev
decreas
hepat
tg
lipas
differenti
factor
respect
ogawa
et
al
ohnogi
et
al
isol
six
new
chalcon
hydroxyxanthoangelol
methoxychalcon
chalcon
furano
chalcon
angelichalcon
togeth
xanthoangelol
evalu
effect
adiponectin
mrna
protein
level
result
isol
except
angelichalcon
increas
express
adiponectin
mrna
product
adiponectin
adipocyt
effect
adiponectin
could
expect
prevent
metabol
syndrom
improv
insulin
resist
dyslipidemia
ohnogi
et
al
xanthoangelol
suppress
adipocyt
differenti
via
ampk
mitogenactiv
protein
kinas
mapk
pathway
result
downregul
express
adipocytespecif
transcript
factor
ccaatenhancerbind
proteinb
cebpb
cebpa
pparc
inhibitori
effect
adipocyt
differenti
could
provid
prevent
effect
obes
obesityrel
disord
zhang
et
al
xanthoangelol
xanthoangelol
f
xanthoangelol
b
xanthoangelol
e
inhibit
phenylephrineinduc
vasoconstrict
among
xanthoangelol
xanthoangelol
f
xanthoangelol
e
show
inhibitori
effect
endotheliumdepend
product
endotheliumderiv
relax
factor
edrf
hand
xanthoangelol
b
directli
inhibit
smooth
muscl
function
reduc
intracellular
free
calcium
ca
elev
induc
phenylephrin
without
affect
edrfno
product
also
suppress
elev
ca
induc
phenylephrin
matsuura
et
al
dietari
reduc
elev
systol
blood
pressur
shrsp
also
support
antihypertens
activ
ogawa
et
al
xanthoangelol
b
xanthoangelol
c
xanthoangelol
e
inhibit
compound
histamin
releas
rat
periton
mast
cell
wherea
xanthoangelol
enhanc
compound
one
immunolog
stimul
activ
mast
cell
induc
allerg
respons
mediat
nakata
baba
selinidin
found
suppress
degranul
leukotrien
synthesi
tumor
necrosi
factora
tnfa
product
without
affect
bind
immunoglobulin
e
ige
high
affin
ige
receptor
fceri
express
cell
surfac
fceri
antigenstimul
primari
mous
bone
marrowderiv
mast
cell
bmmc
selinidin
inhibit
tyrosin
phosphoryl
fceri
bchain
phospholipas
c
fceri
cchain
bmmc
upon
fceri
stimul
demonstr
inhibitori
effect
fceridepend
signal
pathway
phosphoryl
mapk
inhibitori
jba
ijba
also
downregul
selinidin
kishiro
et
al
xanthoangelol
inhibit
activ
nuclear
factorjb
nfjb
involv
attenu
basal
tnfainduc
potent
vasoconstrictor
peptid
inhibitori
effect
nfjb
inflammatori
signal
pathway
could
use
treat
vascular
inflammatori
diseas
mani
vascular
diseas
close
relat
inflammatori
process
sugii
et
al
patent
cover
antiinflammatori
activ
seven
flavonoid
xanthoangelol
xanthoangelol
f
isobavachalcon
deoxyxanthoangelol
h
munduleaflavanon
b
sophoraflavanon
six
coumarin
osthenol
selidinin
peguangxienin
r
angeloyl
khellacton
isolemandin
pteryxin
exud
keiskei
shin
et
al
report
xanthoangelol
xanthoangelol
b
chalcon
show
inhibitori
activ
product
tnfastimul
osteosarcoma
cell
hydroxyl
group
common
shin
et
al
tolllik
receptor
tlr
essenti
induct
innat
immun
respons
invad
pathogen
howev
overexpress
transcript
factor
proinflammatori
gene
activ
tlr
signal
pathway
might
caus
certain
inflammatori
diseas
isobavachalcon
reduc
overexpress
ino
induc
tlr
agonist
lipopeptid
polyriboinosin
polyribocytidyl
acid
lp
murin
macrophag
shin
et
al
xanthoangelol
reduc
product
lpsinduc
tnfa
express
ino
mous
macrophag
moreov
suppress
dna
bind
activ
activ
nfjb
phosphoryl
level
subunit
nfjb
howev
two
chalcon
downregul
nfjb
yasuda
et
al
inhibitori
effect
lpsinduc
express
ino
gene
also
found
xanthoangelol
b
xanthoangelol
e
xanthokeismin
well
mechan
involv
inhibit
ijb
degrad
nfjb
nuclear
transloc
chang
et
al
cynarosid
inhibit
bromobenzeneinduc
hepat
lipid
peroxid
restor
epoxid
hydrolas
activ
liver
rat
park
et
al
xanthoangelol
b
xanthokeismin
xanthokeismin
b
xanthokeismin
c
show
strong
superoxidescaveng
activ
xanthoangelol
isobavachalcon
induc
reduc
nicotinamid
adenin
dinucleotid
phosphat
nad
p
h
quinon
oxidoreductas
protect
quinonemedi
oxid
damag
addit
xanthoangelol
isobavachalcon
angelicol
show
dpph
radic
scaveng
activ
luo
et
al
kim
et
al
ashitabaol
isol
seed
keiskei
found
abund
seed
coat
germin
hplc
analysi
ashitabaol
exhibit
azinobi
acid
abt
free
radic
scaveng
activ
expect
protect
seed
oxid
damag
induc
free
radic
germin
aoki
ohta
xanthin
oxidas
xo
lead
format
free
radic
caus
oxid
damag
live
tissu
xanthoangelol
xanthoangelol
f
isobavachalcon
xanthoangelol
b
show
inhibitori
effect
xo
activ
could
relev
attenu
inflamm
xanthoangelol
e
evalu
effect
arachidon
acid
metabol
gastric
antral
mucosa
platelet
rabbit
xanthoangelol
e
show
signific
effect
product
metabolit
gastric
antral
mucos
slice
wherea
suppress
product
thromboxan
acid
hht
exogen
arachidon
acid
platelet
fujita
et
al
ohkura
et
al
report
xanthoangelol
xanthoangelol
b
xanthoangelol
isol
exud
keiskei
suppress
product
tnfainduc
inhibitor
fibrinolysi
human
umbil
vein
endotheli
cell
huvec
ohkura
et
al
regard
antithrombot
activ
xanthoangelol
also
exhibit
inhibitori
effect
platelet
aggreg
induc
collagen
plateletactiv
factor
phorbol
thrombin
son
et
al
xanthoangelol
compar
iproniazid
antidepress
nonselect
mao
inhibitor
xanthoangelol
inhibit
monoamin
oxidas
mao
nonselect
manner
suppress
dopamin
bhydroxylas
dbh
hand
select
inhibit
maob
mildli
suppress
dbh
higher
deprenyl
select
maob
inhibitor
mao
inhibitor
wide
appli
treat
depress
xanthoangelol
suggest
candid
develop
combin
antidepress
drug
addit
cynarosid
show
strong
inhibitori
effect
dbh
park
et
al
report
xanthoangelol
f
xanthoangelol
b
xanthoangelol
g
xanthoangelol
xanthokeist
inhibitori
effect
hydrolysi
influenza
viru
neuraminidas
na
effect
target
develop
drug
treat
patient
infect
influenza
viru
activ
compound
show
revers
nonselect
characterist
xanthoangelol
potent
inhibitor
furthermor
suggest
influenza
viru
na
inhibitori
activ
alkyl
chalcon
associ
alkyl
group
park
et
al
enzymat
activ
chymotrypsinlik
proteas
pro
papainlik
proteas
pl
pro
essenti
viral
life
cycl
sever
acut
respiratori
syndrom
coroviru
sarscov
two
viral
cystein
proteas
attract
target
develop
antisarscov
drug
xanthoangelol
xanthoangelol
f
isobavachalcon
xanthoangelol
b
xanthoangelol
g
xanthoangelol
xanthoangelol
e
xanthokeist
show
competit
inhibitori
characterist
pro
noncompetit
one
pl
pro
except
mix
inhibit
manner
isobavachalcon
pl
pro
especi
xanthoangelol
e
exhibit
potent
inhibitori
activ
dock
simul
xanthoangelol
e
proteas
reveal
hydroperoxi
group
play
role
enzym
bind
form
hydrogen
bond
park
et
al
angelichalcon
present
osteogenesi
promot
agent
patent
applic
ohnogi
et
al
xanthoangelol
xanthoangelol
h
deoxyxanthoangelol
h
deoxydihydroxanthoangelol
h
exhibit
inhibitori
effect
melanin
format
melanoma
cell
low
cytotox
arung
et
al
present
review
pharmacolog
studi
keiskei
put
activ
compound
support
number
biolog
activ
potenti
impact
human
health
spite
report
biolog
activ
number
file
patent
applic
plant
keiskei
develop
pharmaceut
agent
current
avail
market
health
drink
review
present
summari
studi
publish
date
promis
plant
although
major
studi
mechanist
use
solid
platform
design
conduct
clinic
studi
